心脏调控心力衰竭内分泌反应:对循环脑啡肽酶的贡献
研究利用CARMAT全人工心脏植入患者及不同收缩功能患者的区域采血,探讨可溶性脑啡肽酶(sNEP)的调控。心室切除后循环NPs、糖基化proBNP、furin活性及sNEP立即下降,术后部分恢复;收缩功能减低患者冠状窦sNEP浓度和活性较体循环高约三倍。结论提示心脏在收缩性心衰中通过释放NPs和sNEP调控内分泌反应。
要点
- 心室切除后循环NPs、糖基化proBNP、furin活性及sNEP立即下降。
- 收缩功能减低患者冠状窦sNEP浓度和活性较体循环高约三倍。
- 心脏通过释放sNEP参与调控循环中血管活性肽的生物利用度。
核心结论
- 心脏在收缩性心衰中不仅是NPs来源,还通过贡献循环sNEP调控内分泌反应。
- sNEP影响多种血管活性肽的生物利用度。
研究设计与样本
- 两例接受CARMAT全人工心脏植入患者,术前及术后每周至第6周采集静脉血。
- 收缩功能保留患者6例、左室收缩功能减低患者21例、经肺梯度评估患者5例,比较冠状窦与体循环sNEP。
主要发现
- 心室切除后循环NPs立即下降,糖基化proBNP和furin活性几乎完全消失,sNEP显著降低。
- 术后第1周起NP浓度总体不变,糖基化proBNP、furin活性及sNEP部分恢复。
- 收缩功能保留患者冠状窦与体循环sNEP浓度相似(所有P > 0.05)。
- 左室收缩功能减低患者冠状窦sNEP浓度和活性较体循环高约三倍(n = 21,所有P < 0.0001)。
- 经肺梯度为中性(n = 5,P = 1.0)。
临床怎么用
- 心衰患者sNEP存在区域差异,冠状窦采样可反映心脏局部sNEP贡献。
- 收缩功能减低时心脏来源sNEP可能影响血管活性肽水平,需关注其临床意义。
局限性
- 全人工心脏植入患者样本量小(两例),观察期短(术后6周)。
- 区域采血比较为横断面设计,样本量有限(6例、21例、5例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Heart failure (HF) is accompanied by major neuroendocrine changes including the activation of the natriuretic peptide (NP) pathway. Using the unique model of patients undergoing implantation of the CARMAT total artificial heart and investigating regional differences in soluble neprilysin (sNEP) in patients with reduced or preserved systolic function, we studied the regulation of the NP pathway in HF. METHODS AND RESULTS: Venous blood samples from two patients undergoing replacement of the failing ventricles with a total artificial heart were collected before implantation and weekly thereafter until post-operative week 6. The ventricular removal was associated with an immediate drop in circulating NPs, a nearly total disappearance of circulating glycosylated proBNP and furin activity and a marked decrease in sNEP. From post-operative week 1 onwards, NP concentrations remained overall unchanged. In contrast, partial recoveries in glycosylated proBNP, furin activity, and sNEP were observed. Furthermore, while in patients with preserved systolic function (n = 6), sNEP concentrations in the coronary sinus and systemic vessels were similar (all P > 0.05), in patients with reduced left-ventricular systolic function, sNEP concentration, and activity were ∼three-fold higher in coronary sinus compared to systemic vessels (n = 21, all P < 0.0001), while the trans-pulmonary gradient was neutral (n = 5, P = 1.0). CONCLUSION: The heart plays a pivotal role as a regulator of the endocrine response in systolic dysfunction, not only by directly releasing NPs but also by contributing to circulating sNEP, which in turn determines the bioavailability of other numerous vasoactive peptides.
引用
- Arrigo M, Vodovar N, Nougué H, et al. The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin. Eur Heart J. 2018. PMID: 29244074. doi:10.1093/eurheartj/ehx679
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。